Investors last valued it at $10.2B (Jan 2025). Source ↗
Trying to bring back extinct animals like the woolly mammoth and dire wolf.
Points come from real numbers anyone can check: new job posts, site traffic, software downloads and confirmed news. How scoring works
Facts from news reports, last checked Nov 2026. A free game. No real money. Points are a game score, not a judgment of what a company is worth.
Something wrong, or want this page gone? Fix or remove this page. Removal requests from a company's team are always honored. Founder of Colossal Biosciences? Claim this page for a Founder-verified badge and your own pitch.
Tries to bring back extinct animals, like the woolly mammoth.
If it keeps growing, scientists could learn much more about lost animals and help endangered ones survive.
Once an animal dies out, it is gone for good. Scientists have long wanted a way to bring some of them back.
Scientists change the genes of a close living cousin, such as an elephant, so its cells carry traits of the lost animal.
Investors who back the company. Partners who fund its projects.
A young science business in a narrow, specialized field with few well known rivals.
Why now: Tools for reading and editing genes have become far more precise, so this work is now possible.
Written by AI from the company's public site. Not checked by the company. Something wrong? Fix it.
Nobody has drafted Colossal Biosciences yet. Be the first.